<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font7" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font8" size="7" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font9" size="10" family="Symbol" color="#000000"/>
<text top="41" left="55" width="195" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">BMC Ear, Nose and Throat Disorders 2005, 5 :10<i>BMC Ear, Nose and Throat Disorders</i></text>
<text top="41" left="368" width="186" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.biomedcentral.com/1472-6815/5/10</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="105" segment_no="16" tag_type="text">Page 2 of 7<b>5</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="106" segment_no="17" tag_type="text">(page number not for citation purposes)</text>
<text top="86" left="55" width="241" height="11" font="font4" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="text">an increase in intracellular Ca 2+ ([Ca 2+ ] i ) and/or by an</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="3" segment_no="2" tag_type="text">increase in the Ca 2+ sensitivity of the contractile apparatus</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="2" tag_type="text">[1,2]. One key mechanism enhancing Ca 2+ sensitivity and<i>(page number not for citation purposes)</i></text>
<text top="122" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">thus vascular tone is Rho-kinase signalling, which results</text>
<text top="134" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="2" tag_type="text">in inhibition of myosin light chain phosphatase [2,3].</text>
<text top="145" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="2" tag_type="text">Rho-kinase activation has been shown to cause vasos-</text>
<text top="157" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="2" tag_type="text">pasm of coronary, cerebral and spiral modiolar arteries [4-</text>
<text top="169" left="55" width="11" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="2" tag_type="text">9].</text>
<text top="192" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="6" tag_type="text">One of the strongest Rho-kinase activators described so far</text>
<text top="204" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="6" tag_type="text">is the vasoconstrictor endothelin-1 (ET-1). The synthesis</text>
<text top="216" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="6" tag_type="text">of ET-1 by endothelial cells is activated by physiological</text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="6" tag_type="text">stimuli such as shear stress, insulin, thrombin and other</text>
<text top="239" left="55" width="241" height="11" font="font4" id="p1_t17" reading_order_no="14" segment_no="6" tag_type="text">vascular factors [10]. ET-1 and ET A receptors play a funda-</text>
<text top="251" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="6" tag_type="text">mental role in the maintenance of basal vasomotor tone<a href="">[1,2]. One key mec</a>hanism enhancing Ca</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="6" tag_type="text">in resistance arteries [11]. The synthesis of ET-1 can be</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="6" tag_type="text">increased by hypoxia and elevated oxidized low-density</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="6" tag_type="text">lipoproteins [12,13] and has been implicated in the</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="6" tag_type="text">pathogenesis of a number of cerebrovascular disorders,<a href="">2,3].</a></text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="6" tag_type="text">including stroke, ischemia, and, in particular, cerebral</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="6" tag_type="text">vasospasm [14,15]. Thus, ET-1 possesses pathological<a href="">4-</a></text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="6" tag_type="text">potential in addition to its physiological functions. ET-1 is<a href="">9].</a></text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="6" tag_type="text">present in the SMA and induces strong, long-lasting con-</text>
<text top="357" left="55" width="241" height="10" font="font4" id="p1_t27" reading_order_no="24" segment_no="6" tag_type="text">striction via ET A -receptor-mediated Rho-kinase activation</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="6" tag_type="text">[9,16,17]. Taken together ET-1 is likely an endogenous</text>
<text top="380" left="55" width="174" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="6" tag_type="text">regulator of inner ear microvascular tone.</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="9" tag_type="text">We have previously shown that CGRP is able to reverse<a href="">10]</a>. ET-1 and ET</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="9" tag_type="text">ET-1-induced constrictions in the SMA via an increase in</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="9" tag_type="text">vascular smooth muscle cAMP [18]. CGRP is present in</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="9" tag_type="text">perivascular nerves of the SMA and therefore is a potential</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="9" tag_type="text">endogenous vasodilator of the SMA. We propose, there-<a href="">ries [11]</a>. The synthesis of ET-1 can be</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="9" tag_type="text">fore, that reversal of ET-1-induced constriction is not nec-</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="9" tag_type="text">essarily limited to inhibition of ET-1-related mechanisms<a href="">12,13] an</a>d has been implicated in the</text>
<text top="486" left="55" width="120" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="9" tag_type="text">(e.g., Rho-kinase signalling).</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="10" tag_type="text">These findings provide a clinical perspective for a new</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="10" tag_type="text">treatment of SSHL, because both Rho-kinase signalling<a href="">[14</a>,<a href="">15]. Thu</a>s, ET-1 possesses pathological</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="10" tag_type="text">and cAMP can be targeted via pharmacological agents.</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="10" tag_type="text">Therefore, we assessed the potency of clinically relevant</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="10" tag_type="text">Rho-kinase inhibitors and a cell-permeable analogue</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="10" tag_type="text">cAMP (dbcAMP) in terms of reversing ET-1-induced con-</text>
<text top="580" left="55" width="183" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="10" tag_type="text">striction and Ca 2+ -sensitization in the SMA.</text>
<text top="604" left="55" width="43" height="10" font="font6" id="p1_t45" reading_order_no="42" segment_no="11" tag_type="title">Methods<a href="">[9,16</a>,<a href="">17]. Take</a>n together ET-1 is likely an endogenous</text>
<text top="616" left="55" width="82" height="9" font="font7" id="p1_t46" reading_order_no="43" segment_no="12" tag_type="title">Drugs and solutions</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="14" tag_type="text">The physiologic salt solution (PSS) contained (in mmol/</text>
<text top="639" left="55" width="241" height="10" font="font4" id="p1_t48" reading_order_no="45" segment_no="14" tag_type="text">L) 150 NaCl, 3.6 KC1, 1.0 MgCl 2 , 1.0 CaCl 2 , 5.0 HEPES,</text>
<text top="650" left="55" width="241" height="10" font="font4" id="p1_t49" reading_order_no="46" segment_no="14" tag_type="text">and 5.0 glucose, pH 7.4. Extracellular Ca 2+ concentration<a href="">ooth muscle cAMP [18]. CGRP </a>is present in</text>
<text top="662" left="55" width="241" height="11" font="font4" id="p1_t50" reading_order_no="47" segment_no="14" tag_type="text">([Ca 2+ ] ex ) was raised to 3 and 10 mmol/L by addition of</text>
<text top="674" left="55" width="241" height="11" font="font4" id="p1_t51" reading_order_no="48" segment_no="14" tag_type="text">CaCl 2 . A maximal vasodilation was induced by the</text>
<text top="685" left="55" width="242" height="10" font="font4" id="p1_t52" reading_order_no="49" segment_no="14" tag_type="text">removal of extracellular Ca 2+ . The nominally Ca 2+ -free</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="14" tag_type="text">solution contained (in mmol/L) 150 NaCl, 3.6 KC1, 1.0</text>
<text top="709" left="55" width="241" height="11" font="font4" id="p1_t54" reading_order_no="51" segment_no="14" tag_type="text">MgCl 2 , 1.0 EGTA, 5.0 HEPES, and 5.0 glucose, pH = 7.4.</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="14" tag_type="text">Fluo-4-AM (Molecular Probes) was dissolved in anhy-</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="3" tag_type="text">drous DMSO and stored in 1 mmol/L aliquots. Y-27632</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="3" tag_type="text">was kindly provided by Welfide. Fasudil was obtained</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="3" tag_type="text">from Calbiochem. Fasudil (obtained from Tocris Cook-</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="3" tag_type="text">son) was modified to hydroxyfasudil by Dr. Duy Hua,</text>
<text top="134" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="3" tag_type="text">Dept of Chemistry, Kansas State University. All other</text>
<text top="145" left="313" width="158" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="3" tag_type="text">chemicals were obtained from Sigma.</text>
<text top="169" left="313" width="199" height="9" font="font7" id="p1_t62" reading_order_no="59" segment_no="4" tag_type="title">Preparation of the spiral modiolar artery (SMA)</text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="60" segment_no="5" tag_type="text">Experiments were conducted on tissues isolated from ger-</text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="5" tag_type="text">bils under a protocol that was approved by the Institu-<b>Methods</b></text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="5" tag_type="text">tional Animal Care and Use Committee at Kansas State<i><b>Drugs and solutions</b></i></text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="5" tag_type="text">University. Gerbils were anesthetized with sodium pento-</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="5" tag_type="text">barbital (100 mg/kg i.p.) and decapitated. Temporal</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="5" tag_type="text">bones were removed, opened and placed into a micro-dis-</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="5" tag_type="text">section chamber containing PSS at 4°C. The SMA was iso-</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="5" tag_type="text">lated from the cochlea by micro-dissection as described</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="5" tag_type="text">previously [19]. Briefly, the cochlea was opened. The bone</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="5" tag_type="text">surrounding the modiolus was carefully removed and the</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="5" tag_type="text">SMA, which is only loosely attached to the eighth cranial</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="5" tag_type="text">nerve, was isolated. Care was taken to not stretch the</text>
<text top="322" left="313" width="26" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="5" tag_type="text">artery.</text>
<text top="345" left="313" width="223" height="9" font="font7" id="p1_t76" reading_order_no="73" segment_no="7" tag_type="title">Simultaneous measurement of vascular diameter and</text>
<text top="357" left="313" width="28" height="10" font="font7" id="p1_t77" reading_order_no="74" segment_no="7" tag_type="title">[Ca 2+ ] i</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="8" tag_type="text">The simultaneous measurement of vascular diameter and</text>
<text top="380" left="313" width="241" height="11" font="font4" id="p1_t79" reading_order_no="76" segment_no="8" tag_type="text">[Ca 2+ ] i has been described previously [17]. Briefly, the</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="8" tag_type="text">smooth muscle cells of vessel segments were loaded with</text>
<text top="403" left="313" width="242" height="10" font="font4" id="p1_t81" reading_order_no="78" segment_no="8" tag_type="text">the Ca 2+ indicator dye fluo-4 by incubation in PSS con-</text>
<text top="413" left="313" width="241" height="13" font="font4" id="p1_t82" reading_order_no="79" segment_no="8" tag_type="text">taining 5 µ mol/L fluo-4-AM for 35 min at 37°C. After</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="8" tag_type="text">loading, vessel segments were washed with PSS and main-</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="8" tag_type="text">tained at 4°C for 20 minutes prior to experimentation at</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="8" tag_type="text">37°C. Vessel segments were transferred into a bath cham-</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="8" tag_type="text">ber mounted on the stage of an inverted microscope</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="8" tag_type="text">(Nikon). Fluorescence emitted by fluo-4 (518–542 nm)</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="8" tag_type="text">in response to excitation at 488 nm (Photon Technology</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="8" tag_type="text">International) was detected by a photon counter (Photon</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="8" tag_type="text">Technology International). For measurements of the vas-</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="8" tag_type="text">cular diameter, the vessel was illuminated at 605–615 nm</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="8" tag_type="text">and the transmission image was recorded with a chilled</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="8" tag_type="text">CCD camera (Hamamatsu). The outer vascular diameter</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="8" tag_type="text">was measured by two video edge detectors (Crescent). Flu-</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="8" tag_type="text">orescence and calibrated diameter signals were digitized</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="8" tag_type="text">and recorded simultaneously (Photon Technology Inter-</text>
<text top="592" left="313" width="42" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="8" tag_type="text">national).</text>
<text top="616" left="313" width="98" height="9" font="font7" id="p1_t98" reading_order_no="95" segment_no="13" tag_type="title">Experimental protocols</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t99" reading_order_no="96" segment_no="15" tag_type="text">Experiments were started 20 min after loading with fluo-<i><b>Preparation of the spiral modiolar artery (SMA)</b></i></text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="15" tag_type="text">4. Vessel segments were superfused at a rate of 9 ml/min</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="15" tag_type="text">with PSS. This flow rate corresponds to an exchange rate</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="15" tag_type="text">of 2 bath chambers volumes/sec, given the bath chamber</text>
<text top="672" left="313" width="241" height="13" font="font4" id="p1_t103" reading_order_no="100" segment_no="15" tag_type="text">volume of 75 µ l. Upon start of the superfusion, the</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t104" reading_order_no="101" segment_no="15" tag_type="text">unpressurized artery develops a spontaneous vascular</text>
<text top="697" left="313" width="241" height="10" font="font4" id="p1_t105" reading_order_no="102" segment_no="15" tag_type="text">tone that is sensitive to removal of extracellular Ca 2+ and</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t106" reading_order_no="103" segment_no="15" tag_type="text">inhibition of L-type Ca 2+ channels with nanomolar con-</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t107" reading_order_no="104" segment_no="15" tag_type="text">centrations of nifedipine [19]. The viability of each vessel</text>
</page>
</pdf2xml>
